Authors:
Nyeki, A
Biollaz, J
Kesselring, UW
Decosterd, LA
Citation: A. Nyeki et al., Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment, J CHROMAT B, 755(1-2), 2001, pp. 73-84
Authors:
Vouillamoz-Lorenz, S
Bauer, J
Lejeune, F
Decosterd, LA
Citation: S. Vouillamoz-lorenz et al., Validation of an AAS method for the determination of platinum in biological fluids from patients receiving the oral platinum derivative JM216, J PHARM B, 25(3-4), 2001, pp. 465-475
Authors:
Musfeld, C
Biollaz, J
Belaz, N
Kesselring, UW
Decosterd, LA
Citation: C. Musfeld et al., Validation of an HPLC method for the determination of urinary and plasma levels of N-1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow, J PHARM B, 24(3), 2001, pp. 391-404
Authors:
Marzolini, C
Telenti, A
Decosterd, LA
Greub, G
Biollaz, J
Buclin, T
Citation: C. Marzolini et al., Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients, AIDS, 15(1), 2001, pp. 71-75
Authors:
Marzolini, C
Buclin, T
Decosterd, LA
Biollaz, J
Telenti, A
Citation: C. Marzolini et al., Nelfinavir plasma levels under twice-daily and three-times-daily regimens:High interpatient and low intrapatient variability, THER DRUG M, 23(4), 2001, pp. 394-398
Authors:
Marzolini, C
Telenti, A
Buclin, T
Biollaz, J
Decosterd, LA
Citation: C. Marzolini et al., Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction, J CHROMAT B, 740(1), 2000, pp. 43-58
Authors:
Rappaz, I
Decosterd, LA
Bille, J
Pilet, M
Belaz, N
Roulet, M
Citation: I. Rappaz et al., Continuous infusion of ceftazidime with a portable pump is as effective asthrice-a-day bolus in cystic fibrosis children, EUR J PED, 159(12), 2000, pp. 919-925
Authors:
Marzolini, C
Decosterd, LA
Shen, F
Gander, M
Leyvraz, S
Bauer, J
Buclin, T
Biollaz, J
Lejeune, F
Citation: C. Marzolini et al., Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration (vol 42, pg 433, 1998), CANC CHEMOT, 43(5), 1999, pp. 439-440
Authors:
Rousso, P
Buclin, T
Nussberger, J
Decosterd, LA
La Roche, SD
Brunner-Ferber, F
Brunner, HR
Biollaz, J
Citation: P. Rousso et al., Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100 240, on endocrine and renal functions in healthy volunteers, J HYPERTENS, 17(3), 1999, pp. 427-437
Authors:
Coucke, PA
Decosterd, LA
Li, YX
Cottin, E
Chen, XG
Sun, LQ
Stern, S
Paschoud, N
Denekamp, J
Citation: Pa. Coucke et al., The ribonucleoside diphosphate reductase inhibitor (E)-2 '-deoxy(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitro, CANCER RES, 59(20), 1999, pp. 5219-5226
Authors:
Wilder-Smith, OHG
Ravussin, PA
Decosterd, LA
Despland, PA
Bissonnette, B
Citation: Ohg. Wilder-smith et al., Midazolam premedication and thiopental induction of anaesthesia: interactions at multiple end-points, BR J ANAEST, 83(4), 1999, pp. 590-595
Authors:
Decosterd, LA
Cottin, E
Chen, X
Lejeune, F
Mirimanoff, RO
Biollaz, J
Coucke, PA
Citation: La. Decosterd et al., Simultaneous determination of deoxyribonucleoside in the presence of ribonucleoside triphosphates in human carcinoma cells by high-performance liquidchromatography, ANALYT BIOC, 270(1), 1999, pp. 59-68
Authors:
Decosterd, LA
Buclin, T
Dafflon, M
Leeman, C
Belaz, N
Magnin, JL
Biollaz, J
Citation: La. Decosterd et al., Determination of trace lithium in human erythrocytes by electrothermal atomic-absorption spectrometry with pyrocoated graphite tubes and integrated platform, J PHARM PHA, 50(6), 1998, pp. 693-701